Lexagene Holdings (Lexagene Holdings) EV-to-FCF : -1.77 (As of Jun. 04, 2024)

Lexagene Holdings EV-to-FCF Chart

Lexagene Holdings Annual Data
	Trend	Mar13	Mar14	Mar15	Feb16	Feb17	Feb18	Feb19	Feb20	Feb21	Feb22
EV-to-FCF		Get a 7-Day Free Trial					-13.09	-5.32	-10.96	-10.60	-2.84

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
EV-to-FCF	Get a 7-Day Free Trial															-4.45	-2.84	-2.31	-2.61	-3.41

Competitive Comparison of Lexagene Holdings's EV-to-FCF

For the Medical Devices subindustry, Lexagene Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lexagene Holdings's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's EV-to-FCF falls into.

Lexagene Holdings EV-to-FCF Calculation

Lexagene Holdings's EV-to-FCF for today is calculated as:

Lexagene Holdings's current Enterprise Value is $12.23 Mil.
Lexagene Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lexagene Holdings  (OTCPK:LXXGQ) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Lexagene Holdings's PE Ratio for today is calculated as:

Lexagene Holdings's share price for today is $0.0806.
Lexagene Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.070.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Lexagene Holdings EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (Lexagene Holdings) Business Description